Please Wait...

Jeremiah Rehm

Main profile

Jeremiah Rehm
Jeremiah Rehm
Clinical Solutions Specialist

Jeremiah has been an innovator in Life Sciences for more than 13 years -- the last 8 of those designing and maintaining Clinical Trial Management Systems. Prior to joining Bioclinica, he was a technology consultant and led the product management team for eClinical products acquired by Bioclinica. One of Jeremiah's specialties is in the use of Microsoft applications to consolidate and analyze operational study information, including translation of this data into meaningful performance metrics.

Blogs

Regulatory authorities require clinical trial progress to be monitored. The site visit report, known as the Monitor Visit Report (MVR), is where sponsors provide evidence that all regulated activities have been completed along with documentation of the outcome. These reports are open to regulatory inspection at any time during a study, as well as after, and even post product approval.

CTMS and MVR, Across the Great Divide
As anyone in pharma knows, our industry is undergoing major change; clinical trials are rapidly evolving and eClinical technologies are becoming more sophisticated by the day. Meanwhile site monitoring continues to be one of the most critical, costly, and labor-intensive activities in a clinical trial. Looking for a better way to address this, many organizations have made the switch from conventional CTMS to the "Microsoft Office-Smart" model.

CTMS & eTMF seamless integration at ShareFEST 2013

We've recently heard quite a bit of industry conversation regarding the touch-points between clinical trial management systems (CTMS) and electronic trial master files (eTMF).  In addition to this blog post, we will be discussing this evolving topic in greater depth at the upcoming ShareFEST 2013 conference i

There have recently been a lot of industry conversations regarding the touch-points between clinical trial management systems (CTMS) and Electronic Master Trial Files (eTMF). While there are many questions concerning the integration of CTMS and eTMF, they can mostly be boiled down to the following three:

There has been quite a lot of discussion within the clinical trial management industry regarding new improved CTMS and study setup products. These new CTMS solutions all seem to focus on updating the traditional model with a slick, user-friendly interface as well as overall improved functionality (which is great).

Webinars

December 31, 2019 - 12:00pm (EST)

In this webinar hosted by Chad Ebner, who heads up Bioclinica's App xChange, clinical trial experts Dirk Beth and Jeremiah Rehm will explore the possibilities of single source data across CTMS/eTMF systems. This approach can bring increased efficiencies in a number of important areas, such as elimination of redundant work processes and reconciliation of CTMS/eTMF data.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @eClinical_Jen: FREE on-demand webinars from @bioclinica on EDC, Imaging, RBM, and Clinical Trial Management. Tell them I sent you! http…
bioclinica (Yesterday)
Excited to host NJ Lt. Gov. Kim Guadagno, clients, partners 9/28 in Princeton! In the area? Join us ! RSVP… https://t.co/PrfyxvasGb
bioclinica (3 days ago)
Be sure to follow #ThankAScientist all week to thank researchers for the work they do! https://t.co/Sfi9mmHbSk… https://t.co/y9ZhBXsIzu
bioclinica (3 days ago)
Cardiovascular imaging use is growing in non-cardiovascular areas #ClinicalTrials. See where in Tim Crowe's blog… https://t.co/dYjPBC0Wtn
bioclinica (3 days ago)
RT @Xtalks: Cardiovascular Safety in #Biopharmaceutical Product Development - From QT Prolongation and Beyond @bioclinica https://t.co/mCk1…
bioclinica (3 days ago)
RT @Xtalks: How Innovations in Data Visualization Are Accelerating Data Cleaning and Improving Quality @bioclinica https://t.co/vfLU8pS9Rd
bioclinica (3 days ago)

Latest Blogs: